EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-94 Cr | ₹-713 Cr | ₹-468 Cr | ₹-789 Cr | ₹-252 Cr |
What is the latest Cash Flow from Investing Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-94 Cr |
| Mar2024 | ₹-713 Cr |
| Mar2023 | ₹-468 Cr |
| Mar2022 | ₹-789 Cr |
| Mar2021 | ₹-252 Cr |
How is Cash Flow from Investing Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-94 Cr | Negative | |
| Mar2024 | ₹-713 Cr | Negative | |
| Mar2023 | ₹-468 Cr | Negative | |
| Mar2022 | ₹-789 Cr | Negative | |
| Mar2021 | ₹-252 Cr | - | |
Compare Cash Flow from Investing Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹31,851.9 Cr | 2.4% | 1.6% | 68.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 2.4% |
1.6% |
68.6% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses